Cytek Biosciences shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.1M | 563k | 9.12 |
| 2023-09-30 | $3.0M | 538k | 5.52 |
| 2023-06-30 | $4.9M | 568k | 8.54 |
| 2023-03-31 | $1.9M | 205k | 9.19 |
| 2022-12-31 | $3.7M | 362k | 10.21 |
| 2022-06-30 | $803k | 75k | 10.72 |
| 2022-03-31 | $7.0M | 649k | 10.81 |
| 2021-12-31 | $981k | 60k | 16.33 |
| 2021-09-30 | $1.5M | 69k | 21.41 |